Bloomsbury Publishing (BMY) Competitors

Bloomsbury Publishing logo
GBX 604 -16.00 (-2.58%)
As of 11/20/2026 12:11 PM Eastern

BMY vs. HCM, INDV, VEC, SER, and ERGO

Should you buy Bloomsbury Publishing stock or one of its competitors? Bloomsbury Publishing's main competitors and comparable companies include HUTCHMED (HCM), Indivior (INDV), Vectura Group (VEC), 5533861 (SER.L) (SER), and Ergomed (ERGO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Bloomsbury Publishing compare to HUTCHMED?

Bloomsbury Publishing (LON:BMY) and HUTCHMED (LON:HCM) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, media sentiment, profitability, dividends, risk and institutional ownership.

In the previous week, HUTCHMED had 2 more articles in the media than Bloomsbury Publishing. MarketBeat recorded 2 mentions for HUTCHMED and 0 mentions for Bloomsbury Publishing. HUTCHMED's average media sentiment score of 0.26 beat Bloomsbury Publishing's score of 0.00 indicating that HUTCHMED is being referred to more favorably in the news media.

Company Overall Sentiment
Bloomsbury Publishing Neutral
HUTCHMED Neutral

42.3% of Bloomsbury Publishing shares are held by institutional investors. Comparatively, 20.7% of HUTCHMED shares are held by institutional investors. 3.7% of Bloomsbury Publishing shares are held by insiders. Comparatively, 2.8% of HUTCHMED shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Bloomsbury Publishing currently has a consensus target price of GBX 792.50, suggesting a potential upside of 31.21%. Given Bloomsbury Publishing's stronger consensus rating and higher probable upside, equities research analysts clearly believe Bloomsbury Publishing is more favorable than HUTCHMED.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bloomsbury Publishing
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
HUTCHMED
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

HUTCHMED has a net margin of 163.84% compared to Bloomsbury Publishing's net margin of 6.35%. HUTCHMED's return on equity of 18.42% beat Bloomsbury Publishing's return on equity.

Company Net Margins Return on Equity Return on Assets
Bloomsbury Publishing6.35% 9.42% 7.82%
HUTCHMED 163.84%18.42%-5.90%

Bloomsbury Publishing has higher earnings, but lower revenue than HUTCHMED. Bloomsbury Publishing is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bloomsbury Publishing£318M1.54£37.37M£24.5924.56
HUTCHMED£549.12M3.32-£52.98M£2.00105.00

Bloomsbury Publishing has a beta of 0.418, suggesting that its share price is 58% less volatile than the broader market. Comparatively, HUTCHMED has a beta of 0.428, suggesting that its share price is 57% less volatile than the broader market.

Summary

Bloomsbury Publishing and HUTCHMED tied by winning 8 of the 16 factors compared between the two stocks.

How does Bloomsbury Publishing compare to Indivior?

Indivior (LON:INDV) and Bloomsbury Publishing (LON:BMY) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings.

In the previous week, Indivior's average media sentiment score of 0.00 equaled Bloomsbury Publishing'saverage media sentiment score.

Company Overall Sentiment
Indivior Neutral
Bloomsbury Publishing Neutral

Bloomsbury Publishing has a consensus target price of GBX 792.50, indicating a potential upside of 31.21%. Given Bloomsbury Publishing's stronger consensus rating and higher possible upside, analysts clearly believe Bloomsbury Publishing is more favorable than Indivior.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Indivior
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Bloomsbury Publishing
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

86.0% of Indivior shares are held by institutional investors. Comparatively, 42.3% of Bloomsbury Publishing shares are held by institutional investors. 3.4% of Indivior shares are held by insiders. Comparatively, 3.7% of Bloomsbury Publishing shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Indivior has a beta of 0.19, suggesting that its share price is 81% less volatile than the broader market. Comparatively, Bloomsbury Publishing has a beta of 0.418, suggesting that its share price is 58% less volatile than the broader market.

Indivior pays an annual dividend of GBX 15 per share and has a dividend yield of 1.2%. Bloomsbury Publishing pays an annual dividend of GBX 16.20 per share and has a dividend yield of 2.7%. Indivior pays out -1,243.7% of its earnings in the form of a dividend. Bloomsbury Publishing pays out 65.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Bloomsbury Publishing has a net margin of 6.35% compared to Indivior's net margin of 0.17%. Bloomsbury Publishing's return on equity of 9.42% beat Indivior's return on equity.

Company Net Margins Return on Equity Return on Assets
Indivior0.17% -1.11% 2.37%
Bloomsbury Publishing 6.35%9.42%7.82%

Bloomsbury Publishing has lower revenue, but higher earnings than Indivior. Indivior is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Indivior£1.40B1.38-£2.36M-£1.21N/A
Bloomsbury Publishing£318M1.54£37.37M£24.5924.56

Summary

Bloomsbury Publishing beats Indivior on 13 of the 16 factors compared between the two stocks.

How does Bloomsbury Publishing compare to Vectura Group?

Vectura Group (LON:VEC) and Bloomsbury Publishing (LON:BMY) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

Bloomsbury Publishing has higher revenue and earnings than Vectura Group. Vectura Group is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vectura Group£190.60M0.00N/A£20.10N/A
Bloomsbury Publishing£318M1.54£37.37M£24.5924.56

In the previous week, Vectura Group's average media sentiment score of 0.00 equaled Bloomsbury Publishing'saverage media sentiment score.

Company Overall Sentiment
Vectura Group Neutral
Bloomsbury Publishing Neutral

Bloomsbury Publishing has a consensus price target of GBX 792.50, suggesting a potential upside of 31.21%. Given Bloomsbury Publishing's stronger consensus rating and higher probable upside, analysts clearly believe Bloomsbury Publishing is more favorable than Vectura Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vectura Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Bloomsbury Publishing
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

42.3% of Bloomsbury Publishing shares are owned by institutional investors. 3.7% of Bloomsbury Publishing shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Vectura Group pays an annual dividend of GBX 38 per share. Bloomsbury Publishing pays an annual dividend of GBX 16.20 per share and has a dividend yield of 2.7%. Vectura Group pays out 189.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bloomsbury Publishing pays out 65.9% of its earnings in the form of a dividend. Bloomsbury Publishing is clearly the better dividend stock, given its higher yield and lower payout ratio.

Bloomsbury Publishing has a net margin of 6.35% compared to Vectura Group's net margin of 0.00%. Bloomsbury Publishing's return on equity of 9.42% beat Vectura Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Vectura GroupN/A N/A N/A
Bloomsbury Publishing 6.35%9.42%7.82%

Summary

Bloomsbury Publishing beats Vectura Group on 13 of the 13 factors compared between the two stocks.

How does Bloomsbury Publishing compare to 5533861 (SER.L)?

5533861 (SER.L) (LON:SER) and Bloomsbury Publishing (LON:BMY) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

5533861 (SER.L) pays an annual dividend of GBX 21.15 per share and has a dividend yield of 10.2%. Bloomsbury Publishing pays an annual dividend of GBX 16.20 per share and has a dividend yield of 2.7%. Bloomsbury Publishing pays out 65.9% of its earnings in the form of a dividend.

26.6% of 5533861 (SER.L) shares are held by institutional investors. Comparatively, 42.3% of Bloomsbury Publishing shares are held by institutional investors. 14.3% of 5533861 (SER.L) shares are held by company insiders. Comparatively, 3.7% of Bloomsbury Publishing shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Bloomsbury Publishing has a net margin of 6.35% compared to 5533861 (SER.L)'s net margin of 0.00%. Bloomsbury Publishing's return on equity of 9.42% beat 5533861 (SER.L)'s return on equity.

Company Net Margins Return on Equity Return on Assets
5533861 (SER.L)N/A N/A N/A
Bloomsbury Publishing 6.35%9.42%7.82%

Bloomsbury Publishing has lower revenue, but higher earnings than 5533861 (SER.L).

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
5533861 (SER.L)£973.63M0.83N/AN/AN/A
Bloomsbury Publishing£318M1.54£37.37M£24.5924.56

5533861 (SER.L) currently has a consensus price target of GBX 320, suggesting a potential upside of 54.89%. Bloomsbury Publishing has a consensus price target of GBX 792.50, suggesting a potential upside of 31.21%. Given 5533861 (SER.L)'s higher probable upside, equities research analysts clearly believe 5533861 (SER.L) is more favorable than Bloomsbury Publishing.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
5533861 (SER.L)
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Bloomsbury Publishing
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, 5533861 (SER.L)'s average media sentiment score of 0.00 equaled Bloomsbury Publishing'saverage media sentiment score.

Company Overall Sentiment
5533861 (SER.L) Neutral
Bloomsbury Publishing Neutral

Summary

Bloomsbury Publishing beats 5533861 (SER.L) on 6 of the 11 factors compared between the two stocks.

How does Bloomsbury Publishing compare to Ergomed?

Ergomed (LON:ERGO) and Bloomsbury Publishing (LON:BMY) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

Bloomsbury Publishing has higher revenue and earnings than Ergomed. Ergomed is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ergomed£152.09M0.00£15M£0.29N/A
Bloomsbury Publishing£318M1.54£37.37M£24.5924.56

In the previous week, Ergomed's average media sentiment score of 0.00 equaled Bloomsbury Publishing'saverage media sentiment score.

Company Overall Sentiment
Ergomed Neutral
Bloomsbury Publishing Neutral

71.1% of Ergomed shares are owned by institutional investors. Comparatively, 42.3% of Bloomsbury Publishing shares are owned by institutional investors. 18.2% of Ergomed shares are owned by company insiders. Comparatively, 3.7% of Bloomsbury Publishing shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Bloomsbury Publishing has a consensus target price of GBX 792.50, suggesting a potential upside of 31.21%. Given Bloomsbury Publishing's stronger consensus rating and higher probable upside, analysts plainly believe Bloomsbury Publishing is more favorable than Ergomed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ergomed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Bloomsbury Publishing
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Ergomed has a beta of 0.79, meaning that its stock price is 21% less volatile than the broader market. Comparatively, Bloomsbury Publishing has a beta of 0.418, meaning that its stock price is 58% less volatile than the broader market.

Ergomed has a net margin of 9.87% compared to Bloomsbury Publishing's net margin of 6.35%. Ergomed's return on equity of 18.08% beat Bloomsbury Publishing's return on equity.

Company Net Margins Return on Equity Return on Assets
Ergomed9.87% 18.08% 10.16%
Bloomsbury Publishing 6.35%9.42%7.82%

Summary

Ergomed beats Bloomsbury Publishing on 7 of the 13 factors compared between the two stocks.

Get Bloomsbury Publishing News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BMY vs. The Competition

MetricBloomsbury PublishingPharmaceuticals IndustryHealthcare SectorLON Exchange
Market Cap£488.29M£13.62B£7.78B£2.67B
Dividend Yield2.52%2.58%2.47%5.11%
P/E Ratio24.5627.5233.2222.78
Price / Sales1.546.788.104.91
Price / Cash8.9115.6321.0120.23
Price / Book2.435.164.262.40
Net Income£37.37M£2.86B£3.50B£5.88B
1 Month Performance-10.12%-9.80%-10.48%-4.75%
1 Year Performance25.83%-8.93%-4.61%5.15%

Bloomsbury Publishing Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BMY
Bloomsbury Publishing
2.1301 of 5 stars
GBX 604
-2.6%
GBX 792.50
+31.2%
+22.9%£488.29M£318M24.5634,300
HCM
HUTCHMED
N/AGBX 227
+1.8%
N/A-3.7%£1.97B£549.12M113.501,760
INDV
Indivior
N/AGBX 1,238
+1.6%
N/A+0.0%£1.93B£1.40BN/A1,000
VEC
Vectura Group
N/AN/AN/AN/A£1.01B£190.60M8.209,200
SER
5533861 (SER.L)
N/AGBX 226.20
-0.3%
GBX 320
+41.5%
N/A£886.51M£973.63MN/AN/A

Related Companies and Tools


This page (LON:BMY) was last updated on 11/21/2026 by MarketBeat.com Staff.
From Our Partners